Epigenica offers the EpiFinder platform for high-throughput epigenetic analysis and R&D services in therapeutic and diagnostic development.
Epigenica has raised $2.2M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
Epigenica's investors include Voima Ventures, Almi Invest, Navigare Ventures, Leksell Social Ventures.
Epigenica is headquartered in Solna, Sweden.
Epigenica offers the EpiFinder platform for high-throughput epigenetic analysis and R&D services in therapeutic and diagnostic development.
Epigenica is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Epigenica — Funding & Investors." VCBacked, June 30, 2025, https://www.vcbacked.co/company/epigenica. Accessed September 15, 2026.
VCBacked. (2025). Epigenica — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/epigenica
{{cite web |title=Epigenica — Funding & Investors |url=https://www.vcbacked.co/company/epigenica |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated